Growth Metrics

Integra Lifesciences Holdings (IART) Cash from Investing Activities (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 57.46%
Dec 31, 2025 -123.94%
Sep 30, 2025 27.99%
Jun 30, 2025 39.73%
Mar 31, 2025 -745.38%
Dec 31, 2024 59.13%
Sep 30, 2024 96.77%
Jun 30, 2024 -497.05%
Mar 31, 2024 5.70%
Dec 31, 2023 -643.52%
Sep 30, 2023 50.50%
Jun 30, 2023 -13.46%
Mar 31, 2023 75.00%
Dec 31, 2022 -470.28%
Sep 30, 2022 429.15%
Jun 30, 2022 68.02%
Mar 31, 2022 48.82%
Dec 31, 2021 -224.31%
Sep 30, 2021 -7.05%
Jun 30, 2021 93.27%
Mar 31, 2021 -227.29%
Dec 31, 2020 -434.70%
Sep 30, 2020 -70.12%
Jun 30, 2020 81.62%
Mar 31, 2020 -4.25%
Dec 31, 2019 81.06%
Sep 30, 2019 -525.01%
Jun 30, 2019 -10.17%
Mar 31, 2019 37.60%
Dec 31, 2018 -54.99%
Sep 30, 2018 -1,390.92%
Jun 30, 2018 113.62%
Mar 31, 2018 99.05%
Dec 31, 2017 -13,739.43%
Sep 30, 2017 81.06%
Jun 30, 2017 80.58%
Mar 31, 2017 -813.55%
Dec 31, 2016 -215.22%
Sep 30, 2016 16.61%
Jun 30, 2016 -19.51%
Mar 31, 2016 82.20%
Dec 31, 2015 88.01%
Sep 30, 2015 -3,178.06%
Jun 30, 2015 -366.91%
Mar 31, 2015 97.92%
Dec 31, 2014 -1,026.51%
Sep 30, 2014 6.21%
Jun 30, 2014 96.20%
Mar 31, 2014 -5,282.02%
Dec 31, 2013 65.83%
Sep 30, 2013 2.15%
Jun 30, 2013 -4.59%
Mar 31, 2013 56.04%
Dec 31, 2012 -249.95%
Sep 30, 2012 459.50%
Jun 30, 2012 91.35%
Mar 31, 2012 -309.86%
Dec 31, 2011 80.74%
Sep 30, 2011 8.12%
Jun 30, 2011 -1,386.24%
Mar 31, 2011 69.23%
Dec 31, 2010 -114.92%
Dec 31, 2009 -677.13%